Risk factors and outcomes of fungal Ventricular-Assist device infections

Clinical Infectious Diseases

Volumn 50, Issue 5, 2010, Pages 664-671

  Aslam, Saima ^a,b,c   Hernandez, Maria ^a   Thornby, John ^c   Zeluff, Barry ^b   Darouiche, Rabih O ^a,c  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b Section of Infectious Diseases   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN;

ADULT; ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; DEVICE INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; FEMALE; HEART ASSIST DEVICE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOTAL PARENTERAL NUTRITION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; FEMALE; FUNGI; HUMANS; MALE; MIDDLE AGED; MYCOSES; PARENTERAL NUTRITION; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 76749095361     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650454     Document Type: Article

References (24)

1. 1. DeRose JJ Jr, Umana JP, Argenziano M, et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 1997;30:1773-1777. (Pubitemid 27521261)
2. 2. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-1443. (Pubitemid 34936630)
3. 3. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186-1195. (Pubitemid 33590445)
4. 4. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. Asaio J 2005;51:461-470. (Pubitemid 41076784)
5. 5. Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 2004;164:842-850. (Pubitemid 38520624)
6. Aslam S. Effect of antibacterials on biofilms. Am J Infect Control 2008;36: S175e9-e11.
7. 7. Donlan R, Costerton JW. Biofilms: survival mechanisms of clinically relevant microoganisms. Clin Micro Rev 2002; 15:167-193. (Pubitemid 34303762)
8. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis 2006; 6:426-437.
9. 9. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005; 40: 1108-1115. (Pubitemid 40490234)
10. Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004;23:1359-1365.
11. 11. Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant 2003;22:914-921. (Pubitemid 36945491)
12. 12. Monkowski DH, Axelrod P, Fekete T, Hollander T, Furukawa S, Samuel R. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 2007; 9: 114-120. (Pubitemid 46669080)
13. 13. Morgan JA, John R, Rao V, et al. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg 2004;127:1309-1316. (Pubitemid 38560592)
14. Hernandez MD, Mansouri MD, Aslam S, Zeluff B, Darouiche RO. Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices. Infect Control Hosp Epidemiol 2009; 30(2):190-192.
15. Goldstein DJ, el-Amir NG, Ashton RC Jr, et al. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. Asaio J 1995; 41:873-875.
16. 16. Ankersmit HJ, Edwards NM, Schuster M, et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 1999; 100:11211-11215. (Pubitemid 29523537)
17. 17. Ankersmit HJ, Tugulea S, Spanier T, et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 1999; 354:550-555. (Pubitemid 29381369)
18. Zilberberg MD, Shorr AF. Fungal infections in the ICU. Infect Dis Clin North Am 2009; 23:625-642.
19. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758.
20. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-421.
21. 21. Skinner JL, Harris C, Aaron MF, et al. Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices. Asaio J 2000; 46: 587-589. (Pubitemid 30696323)
22. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11:30-36.
23. Mukherjee PK, Long L, Kim HG, Ghannoum MA. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms. Int J Antimicrob Agents 2009; 33:149-153.
24. Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 2009; 64:567-570.